| アブストラクト | BACKGROUND: Migraine is a chronic disease characterized by episodic headache attacks. No recent studies have, however been conducted on the epidemiology of migraine or the treatment landscape in Japan. This study was conducted as a fact-finding survey using medical claims data and an online survey on migraine and headaches, conducted among members of health insurance associations with the objective of gaining an understanding of migraine prevalence and the treatment status in Japan. METHODS: The study methodology utilized a unique approach of combined data sources. The data sources used in this study are medical claims data and linked online survey data provided by DeSC Healthcare Inc (DeSC). The primary outcomes (from survey responses) were: the overall number and proportion of migraine patients; and the overall prevalence of migraine, stratified by age and sex. The secondary outcomes (from survey responses) were use of medical care; and clinical features/headache symptoms. The analysis population included all individuals who had response data for surveys conducted by DeSC. The online survey data and medical claims data were summarized. RESULTS: The data population comprised 21,480 individuals. On the basis of the survey results, including probable cases, the overall prevalence of migraine was 3.2%. The highest prevalence of migraine was observed in patients aged 30-39 years. The prevalence of migraine in women was 4.4 times higher than in men. The percentage of migraine patients who had not been seen by a doctor was 81.0%. More than 80% of patients were taking over-the-counter drugs and 4.8% took prescription medicines only. Approximately 52.9% of patients considered that the intensity of pain symptoms was severe. Moreover, the majority of patients (72.9%) considered that the impairment of daily life activities was of moderate or severe degree. CONCLUSIONS: In Japan, the percentage of people with migraine who did not receive medical attention is as high as 80%. Additionally, the majority of patients tend to endure symptoms and continue with everyday activities. With innovative treatment approaches becoming available it is necessary to disseminate information that migraine is not a simple headache but an illness that requires medical treatment and consultation. |
|---|
| 組織名 | Saitama International Headache Center, Saitama Neuropsychiatric Institute, 6-11-1;Honmachi-Higashi, Chuo-ku, Saitama, 338-8577, Japan.;Department of Neurology, Dokkyo Medical University, 880 Kitakobayashi, Mibu,;Shimotsuga, Tochigi, 321-0293, Japan.;Department of Internal Medicine, Headache Care Unit, Fujitsu Clinic, 4-1-1;Kamikodanaka, Nakahara-ku, Kawasaki, Kanagawa, 211-8588, Japan.;Headache Center, Department of Neurology, Tominaga Hospital, 1-4-48 Minatomachi,;Naniwa-ku, Osaka-shi, Osaka, 556-0017, Japan.;Department of Health Informatics, Graduate School of Medicine and School of;Public Health, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, 606-8501,;Japan.;Medical Affairs, Otsuka Pharmaceutical Co., Ltd, 3-2-27 Otedori, Chuo-ku, Osaka,;540-0021, Japan. sanoh@otsuka.jp.;Medical Affairs, Otsuka Pharmaceutical Co., Ltd., Shinagawa Grand Central Tower,;2-16-4, Konan, Minato-ku, Tokyo, 108-8242, Japan.;Medical Affairs, Otsuka Pharmaceutical Co., Ltd., 463-10 Kagasuno, Kawauchi-cho,;Tokushima, 771-0192, Japan. |
|---|
